Decreased Watchlist Percentage
Reduced watchlist percentage from 13% in Q4 2023 to 8% in Q4 2024, indicating improved asset management outcomes.
Strong Liquidity Position
Maintained strong liquidity with $685 million available at the end of Q4 2024 and no corporate maturities until 2027.
Repayment and Origination Activity
Fourth quarter repayments exceeded $450 million, with full-year repayments totaling $1.5 billion. Expect originations to outpace repayments in the near term.
Proactive Management of CECL Allowance
Modified San Carlos Life Science loan, resulting in a $36 million subordinated note write-off and a decrease in total CECL reserve to $120 million.